
Invicta Diagnostic
Open Date
01 Dec 2025
Close Date
03 Dec 2025
Min Investment
₹272000
Lot Size
3200 Shares
Issue Size
₹28.12 Cr
Price Range
₹80 - ₹85
Listing Date
Dec 8, 2025
IPO Doc
RHP PDFAbout Invicta Diagnostic
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology and radiology testing comprising imaging, radiology, pathology, and teleradiology services under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra.Invicta Diagnostics Limited, trading as PC Diagnostics, is a Mumbai-based diagnostic services company specializing in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:A flagship hub offering full-spectrum pathology and advanced radiology (CT, MRI) at Thane WestThree other centres - Bhayandar, Byculla, Marol - offering specialized diagnostic servicesBasic imaging, including X-ray and ultrasound, and sample collection were the focus of spokes at Lower Parel, Sewri, Mazgaon, and Kalwa.It offers approximately 60 routine and 487 specialized pathology tests and around 96 basic and 130 advanced radiology investigations.Invicta Diagnostics provides a comprehensive suite of diagnostic services that includes:Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panelsSpecialized Tests: Molecular diagnostics, immunoassays, infectious disease markers including dengue, COVID-19, cancer markers, and genetic panels.Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres. The company has a network of 5 laboratory doctors, 20 radiologists, and 127 well-trained technical staff as of May 31st, 2025. The company has 105 permanent employees as of May 31, 2025.
Checklist Quality Analysis
Revenue Growth
Company Valuation
Earning Expansion
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.
Invicta Diagnostic IPO - Issue Objectives
21.11 crore will fund new medical equipment and five diagnostic centres in Maharashtra. Part of the IPO proceeds will be used for general corporate purposes
Capital Expenditure Requirements
75.07%
General corporate purposes
24.93%
Capital Expenditure Requirements
21.11 crore will fund new medical equipment and five diagnostic centres in Maharashtra.
General corporate purposes
Part of the IPO proceeds will be used for general corporate purposes
IPO Subscription Status
Financials of Invicta Diagnostic
In Cr.
Revenue: ₹17.08
EBITDA: ₹6.77
Profit: ₹4.08
| Key Performance Indicator | 30-Sep-25 (In Cr.) | 31-Mar-25 (In Cr.) | 31-Mar-24 (In Cr.) |
|---|---|---|---|
| Revenue | 17.08 | 30.18 | 15.90 |
| EBITDA | 6.77 | 9.20 | 7.09 |
| Expenses | |||
| Profit After Tax | 4.08 | 4.93 | 3.81 |
| Assets | 34.90 | 21.22 | 15.89 |
| Net Worth | 23.68 | 13.60 | 8.67 |
| Reserves | 14.42 | 5.18 | 8.54 |
| Borrowing | 3.72 | 3.54 | 3.81 |
Invicta Diagnostic - Promoter(s)
Dr. Ketan Jayantilal Jain
Dr. Sanket Vinod Jain
Rohit Prakash Srivastava
Badal Kailash Naredi
Jayesh Prakash Jain
N/A
N/A
Contact Details
Invicta Diagnostic
1 GF, Plot 217, Ambavat Bhavan, N.M Joshi Marg, Delisle Road, Mumbai, Maharashtra, 400013
Registrar Contact Details
Bigshare Services Pvt Ltd
Invicta Diagnostic IPO - FAQs
Live IPOs
CMR Green Technologies
Vahh Chemicals
UHM Vacation
| Companies Name | Open - Close | Issue Size | Min. Qty | Issue Price | Apply |
|---|---|---|---|---|---|
CMR Green Technologies Mainboard BSE NSE | 3rd Jun 2026 - 5th Jun 2026 | 630.88 Cr | 78 Shares | ₹ 182.00 | |
Vahh Chemicals SME | 4th Jun 2026 - 8th Jun 2026 | 13.45 Cr | 2000 Shares | ₹ 60.00 | |
UHM Vacation SME | 4th Jun 2026 - 8th Jun 2026 | 36.02 Cr | 800 Shares | ₹ 166.00 | |
Hexagon Nutrition Mainboard | 5th Jun 2026 - 9th Jun 2026 | 138.87 Cr | 333 Shares | ₹ 42.00 |